Cognition in clinical pharmacology studies

Examining changes in cognition in clinical pharmacology studies, with an emphasis on the importance of starting early in clinical development. As world class providers of cognitive assessments, Cognitive Research Corporation and Altasciences Clinical Research join forces to discuss the current industry standards for cognitive assessments. This webinar will focus on how to use cognitive assessments as a safety tool in first-in-human studies and as a measure of potential cognitive improvements or impairments in Phase II studies. It will also address the need for performing driving simulation studies to satisfy the FDA guidance. What will you learn? FDA guidance and the...

To view this content, please register now for access

It's completely free